Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking
Sign up in minutes with your work or personal email
GLP-1 drugs research: summary GLP1 drugs may move beyond diabetes and weight loss into multidisease therapies This could significantly increase the number and profile of users, including nonobese and older populations Innovations such as oral GLP1s may further accelerate uptake and accessibility For food and beverage, the shift needs to be watched closely to understand behaviour change, consumption patterns and nutritional needs GLP-1s started life as diabetes medications, then took the world by storm for treating obesity
GLP-1 medications slow gastric emptying
GLP-1 drugs enhance this response, which can be particularly helpful among people with type 2 diabetes, who may have a reduced natural GLP-1 response
No med fixes chronic sleep deprivation
US$ 21.35
US$ 28.80
US$ 29.57
US$ 28.95
US$ 24.72
US$ 20.76
